Found: 123
Select item for more details and to access through your institution.
Enzalutamide in castration-resistant prostate cancer patients with visceral disease in the liver and/or lung: Outcomes from the randomized controlled phase 3 AFFIRM trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I study of intermittent olaparib capsule or tablet dosing in combination with carboplatin and paclitaxel (part 2).
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 4, p. 1096, doi. 10.1007/s10637-019-00857-6
- By:
- Publication type:
- Article
Phase I study of continuous olaparib capsule dosing in combination with carboplatin and/or paclitaxel (Part 1).
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 4, p. 1117, doi. 10.1007/s10637-019-00856-7
- By:
- Publication type:
- Article
Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 5, p. 995, doi. 10.1007/s10637-014-0101-x
- By:
- Publication type:
- Article
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 760, doi. 10.1007/s10637-012-9869-8
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of 3′-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 1, p. 316, doi. 10.1007/s10637-010-9535-y
- By:
- Publication type:
- Article
Multiparametric bone MRI can improve CT-guided bone biopsy target selection in cancer patients and increase diagnostic yield and feasibility of next-generation tumour sequencing.
- Published in:
- European Radiology, 2022, v. 32, n. 7, p. 4647, doi. 10.1007/s00330-022-08536-6
- By:
- Publication type:
- Article
Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2017, v. 120, n. 5B, p. E30, doi. 10.1111/bju.13631
- By:
- Publication type:
- Article
Circulating biomarkers of neuroendocrine prostate cancer: an unmet challenge.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Final quality of life and safety data for patients with metastatic castration-resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme (EAP) ( NCT01254279).
- Published in:
- BJU International, 2015, v. 116, n. 6, p. 880, doi. 10.1111/bju.13069
- By:
- Publication type:
- Article
Is there an antiandrogen withdrawal syndrome with enzalutamide?
- Published in:
- BJU International, 2015, v. 115, n. 3, p. 373, doi. 10.1111/bju.12826
- By:
- Publication type:
- Article
Enzalutamide in European and North American men participating in the AFFIRM trial.
- Published in:
- BJU International, 2015, v. 115, n. 1, p. 41, doi. 10.1111/bju.12898
- By:
- Publication type:
- Article
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193689
- By:
- Publication type:
- Article
Therapy monitoring of skeletal metastases with whole-body diffusion MRI.
- Published in:
- Journal of Magnetic Resonance Imaging, 2014, v. 39, n. 5, p. 1049, doi. 10.1002/jmri.24548
- By:
- Publication type:
- Article
Managing Metastatic Castration-Resistant Prostate Cancer in the Pre-chemotherapy Setting: A Changing Approach in the Era of New Targeted Agents.
- Published in:
- Drugs, 2016, v. 76, n. 4, p. 421, doi. 10.1007/s40265-015-0530-7
- By:
- Publication type:
- Article
Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 362, p. 1, doi. 10.1126/scitranslmed.aaf9246
- By:
- Publication type:
- Article
Reappraisal of glucocorticoids in castrate-resistant prostate cancer.
- Published in:
- Asian Journal of Andrology, 2014, v. 16, n. 5, p. 666, doi. 10.4103/1008-682X.133314
- By:
- Publication type:
- Article
Safety, efficacy and survival of patients with primary malignant brain tumours (PMBT) in phase I (Ph1) trials: the 12-year Royal Marsden experience.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 139, n. 1, p. 107, doi. 10.1007/s11060-018-2847-z
- By:
- Publication type:
- Article
PARP Inhibitors Mechanism of Action and Their Potential Role in the Prevention and Treatment of Cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Management of Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Neutropenia, neutrophilia, and neutrophil–lymphocyte ratio as prognostic markers in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221100022
- By:
- Publication type:
- Article
A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 7, p. 1131, doi. 10.1038/s41416-023-02436-2
- By:
- Publication type:
- Article
A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 6, p. 965, doi. 10.1038/s41416-023-02380-1
- By:
- Publication type:
- Article
A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours.
- Published in:
- 2021
- By:
- Publication type:
- journal article
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Novel drugs targeting the androgen receptor pathway in prostate cancer.
- Published in:
- Cancer & Metastasis Reviews, 2014, v. 33, n. 2/3, p. 567, doi. 10.1007/s10555-013-9472-2
- By:
- Publication type:
- Article
Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics.
- Published in:
- Cancer & Metastasis Reviews, 2014, v. 33, n. 2/3, p. 555, doi. 10.1007/s10555-013-9473-1
- By:
- Publication type:
- Article
Phase I trials in patients with relapsed, advanced upper gastrointestinal carcinomas: experience in a specialist unit.
- Published in:
- Gastric Cancer, 2014, v. 17, n. 4, p. 621, doi. 10.1007/s10120-013-0328-9
- By:
- Publication type:
- Article
Characterisation of the Phosphatidylinositol 3-Kinase Pathway in Non-Small Cell Lung Cancer Cells Isolated from Pleural Effusions.
- Published in:
- Oncology, 2016, v. 90, n. 5, p. 280, doi. 10.1159/000444928
- By:
- Publication type:
- Article
Clinical Benefit of New Targeted Agents in Phase I Trials in Patients with Advanced Colorectal Cancer.
- Published in:
- Oncology, 2009, v. 76, n. 3, p. 151, doi. 10.1159/000195884
- By:
- Publication type:
- Article
A single‐centre study evaluating a geriatric screening tool in oncology phase I trial patients.
- Published in:
- Cancer Reports, 2024, v. 7, n. 6, p. 1, doi. 10.1002/cnr2.2083
- By:
- Publication type:
- Article
Systematic study of tissue factor expression in solid tumors.
- Published in:
- Cancer Reports, 2023, v. 6, n. 2, p. 1, doi. 10.1002/cnr2.1699
- By:
- Publication type:
- Article
Preclinical Evaluation of Imaging Biomarkers for Prostate Cancer Bone Metastasis and Response to Cabozantinib.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 4, p. 1, doi. 10.1093/jnci/dju033
- By:
- Publication type:
- Article
Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Men Treated With Second-Line Chemotherapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 22, p. 1729, doi. 10.1093/jnci/djt280
- By:
- Publication type:
- Article
Heterogeneity of advanced prostate cancer: clinical implications of genomics.
- Published in:
- Trends in Urology & Men's Health, 2017, v. 8, n. 5, p. 24, doi. 10.1002/tre.598
- By:
- Publication type:
- Article
The evolving role of germline genetic testing and management in prostate cancer: Report from the Princess Margaret Cancer Centre international retreat.
- Published in:
- Canadian Urological Association Journal, 2021, v. 15, n. 12, p. E623, doi. 10.5489/cuaj.7383
- By:
- Publication type:
- Article
Metabolomic changes of the multi (-AGC-) kinase inhibitor AT13148 in cells, mice and patients are associated with NOS regulation.
- Published in:
- Metabolomics, 2020, v. 16, n. 4, p. 1, doi. 10.1007/s11306-020-01676-0
- By:
- Publication type:
- Article
FGF Receptor Inhibitors: Role in Cancer Therapy.
- Published in:
- Current Oncology Reports, 2012, v. 14, n. 2, p. 111, doi. 10.1007/s11912-012-0225-0
- By:
- Publication type:
- Article
Targeted α-Based Treatment of Metastatic Castration-Resistant Prostate Cancer: Revolutionizing Systemic Radiotherapy?
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 12, p. 1838, doi. 10.2967/jnumed.116.179887
- By:
- Publication type:
- Article
Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical validation of circulating GDF15/MIC‐1 as a marker of response to docetaxel and survival in men with metastatic castration‐resistant prostate cancer.
- Published in:
- Prostate, 2024, v. 84, n. 8, p. 747, doi. 10.1002/pros.24691
- By:
- Publication type:
- Article
Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses.
- Published in:
- Oncologist, 2022, v. 27, n. 10, p. e783, doi. 10.1093/oncolo/oyac172
- By:
- Publication type:
- Article
Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses.
- Published in:
- Oncologist, 2022, v. 27, n. 9, p. e783, doi. 10.1093/oncolo/oyac172
- By:
- Publication type:
- Article
Post Hoc Health‐Related Quality of Life Analysis According to Response Among Patients with Prostate Cancer in the PROSELICA and FIRSTANA Studies.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1179, doi. 10.1002/onco.13803
- By:
- Publication type:
- Article
Phase I Study of Nintedanib Incorporating Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Patients With Advanced Solid Tumors.
- Published in:
- Oncologist, 2015, v. 20, n. 4, p. 368, doi. 10.1634/theoncologist.2014-0250
- By:
- Publication type:
- Article
Novel Therapeutic Strategies for Metastatic Prostate Cancer in the Post-Docetaxel Setting.
- Published in:
- Oncologist, 2011, v. 16, n. 11, p. 1487, doi. 10.1634/theoncologist.2010-0412
- By:
- Publication type:
- Article
Revisiting the Role of Antiandrogen Strategies in Ovarian Cancer.
- Published in:
- Oncologist, 2011, v. 16, n. 10, p. 1413, doi. 10.1634/theoncologist.2011-0164
- By:
- Publication type:
- Article
Therapeutics targeting signal transduction for patients with colorectal carcinoma.
- Published in:
- British Medical Bulletin, 2002, v. 64, n. 1, p. 227, doi. 10.1093/bmb/64.1.227
- By:
- Publication type:
- Article